Market Brief
U.S. Mid-Atlantic Region Sees Strong Life Science Capital Construction Activity, an Industrial Info Market Brief
Across the Mid-Atlantic region of the U.S. (Maryland, North Carolina, South Carolina, Virginia and West Virginia), the life science capital construction segment is continuing to experience strong activity and growth
Industrial Info's Pharma/Bio group is currently reporting on 172 major capital projects valued at $12.2 billion in this region. Click here for a list. The leading life science projects by total investment value in this region include: Novo Nordisk in Clayton, North Carolina ($1.85 billion); Merck in Elkton, Virginia ($1 billion), Merck in Durham, North Carolina ($650 million); and Pfizer in Sanford, North Carolina ($500 million).
See the heat map below, showing the amount of Pharma/Bio activity in the region.
Want More IIR News?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Learn MoreRelated Articles
-
Industrial Manufacturing, Pharma Propel Virginia to $10 Bill...August 26, 2022
-
Pharma-Biotech, Food & Beverage Take Lead in North Carolina'...August 19, 2021
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Learn MoreIndustry Intel
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025
-
2025 Global Oil & Gas Project Spending OutlookOn-Demand Podcast / Oct. 24, 2025